Plan B Approval Is Good News for OTC Switch of Xenical
This article was originally published in RPM Report
Executive Summary
FDA's fitful handling of Barr's OTC switch application for the emergency contraceptive Plan B has provided great political theater. But for GSK and Roche, the issue was a complication for the OTC switch of the weight loss drug orlistat. Now the path looks clear.